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Conclusion A similar adaptation of hepatic lipids to both 
fasting and an HFD suggests common mechanisms of lipid 
traﬃcking from adipose tissue to the liver. Altered hepatic 
lipid handling with fasting indicates imperfect metabolic 
recovery from HFD exposure.
Keywords Insulin resistance · Liver · Nuclear Magnetic 
Resonance · Nutrition · Obesity · Polyunsaturated fat
Introduction
The sedentary lifestyle and unrestricted intake of high-
caloric food products experienced currently in Western soci-
eties has caused obesity to reach pandemic proportions [1]. 
The economic, social, and health burdens of this phenome-
non are further aggravated by associated metabolic diseases, 
notably type 2 diabetes [2]. High-fat diet (HFD) feeding is 
a widely used experimental model to study obesity and its 
associated metabolic complications. It has been established 
that prolonged exposure to an HFD not only causes obesity 
but also compromises liver and adipose tissue physiology, 
and perturbs beta-cell function [3–6].
Obesity represents a situation of positive whole-body 
energy balance that favors energy storage and ultimately 
ectopic deposition in the liver. The liver is a major par-
ticipant in whole-body metabolism, and the progression 
of metabolic disease is largely determined by hepatic lipid 
handling. In the liver, lipid intermediates are involved in 
molecular mechanisms that lead to hepatic insulin resist-
ance and hyperglycemia [7]. On the other hand, hepatic 
lipid accumulation without obesity has also been reported 
on short-term exposure to an HFD in both rodents [8, 9] and 
healthy humans [10, 11].
Abstract 
Objective We monitored hepatic lipid content (HLC) and 
fatty acid (FA) composition in the context of enhanced lipid 
handling induced by a metabolic high-fat diet (HFD) chal-
lenge and fasting.
Materials and methods Mice received a control diet (10% 
of kilocalories from fat, N = 14) or an HFD (45% or 60% of 
kilocalories from fat, N = 10 and N = 16, respectively) for 
26 weeks. A subset of ﬁve mice receiving an HFD (60% of 
kilocalories from fat) were switched to the control diet for 
the ﬁnal 7 weeks. At nine time points, magnetic resonance 
spectroscopy was performed in vivo at 14.1 T, interleaved 
with glucose tolerance tests.
Results Glucose intolerance promptly developed with the 
HFD, followed by a progressive increase of fasting insulin 
level, simultaneously with that of HLC. These metabolic 
defects were normalized by dietary reversal. HFD feed-
ing immediately increased polyunsaturation of hepatic 
FA, before lipid accumulation. Fasting-induced changes 
in hepatic lipids (increased HLC and FA polyunsaturation, 
decreased FA monounsaturation) in control-diet-fed mice 
were not completely reproduced in HFD-fed mice, not even 
after dietary reversal.
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Studies with genetically modified mice report that 
increased storage of triglycerides per se does not have a dele-
terious eﬀect on insulin sensitivity [12, 13]. However, and in 
contrast to these models, hepatic lipid accumulation on HFD 
feeding is not an essential hepatic defect but rather a result 
of increased fatty acid (FA) uptake [14, 15]. In addition, an 
early association between HFD feeding and hepatic insulin 
resistance has been reported [8, 9, 16]. Increased hepatic FA 
inﬂux leading to lipid accumulation is also observed with 
prolonged fasting, on mobilization of adipose stores [17–19], 
but in this case hepatic insulin resistance is not present [18]. 
Thus, alterations in the hepatic lipid pool are a physiologi-
cal response to increased circulating FA levels, and are not 
necessarily associated with changes in insulin sensitivity.
Not only the amount of fat in the diet but also its quali-
tative FA composition inﬂuences the extent of hepatic FA 
uptake, hepatic FA accumulation, and ensuing metabolic 
defects. It has been shown that diets rich in saturated FA 
(SFA) cause greater metabolic damage than those rich 
in monounsaturated FA (MUFA) or polyunsaturated FA 
(PUFA) [6, 20, 21]. Although the unsaturation features of 
FA in hepatic triglycerides were shown to mirror those of 
the diet after long-term exposure in rats [21], tracer methods 
found that dietary fat is not the major source of hepatic lipids 
during exogenous lipid delivery [22–24]. Hence, it remains 
to be fully elucidated how the composition of the hepatic 
FA pool progressively adapts to changes in dietary fat, and 
whether there is a relation with metabolic variables during 
this adaptation.
In the present study we aimed at elucidating the evolu-
tion of the hepatic lipid signature in the context of HFD-
induced metabolic damage, noninvasively, by proton mag-
netic resonance spectroscopy (1H-MRS) in vivo over a period 
of 26 weeks in mice. In anticipation of an eﬀect of dietary 
fat load on the phenotype, mice were exposed to diets whose 
composition diﬀered in the amount of lard-derived fat com-
ponent (rich in SFA). We further evaluated the reversibility of 
the HFD-induced phenotype by performing a dietary switch 
from an HFD to the control diet for the ﬁnal 7 weeks of the 
study in a subset of mice. In addition, we also investigated 
the adaptation of hepatic lipids to fasting, when endogenous 
lipid traﬃcking is physiologically enhanced, and whether this 
adaptation would be sensitive to the dietary interventions.
Materials and methods
Animal protocol
Animal experiments were performed with the approval by 
the local ethics committee (Service de la Consommation et 
des Aﬀaires Vétérinaires, Epalinges, Switzerland). Eleven-
week-old male C57BL/6J mice (Charles River Laboratories, 
L’Arbresle, France) were housed with a 12-h light, 12-h dark 
cycle (lights on from 7 a.m.) and allowed 1 week of accli-
matization before experiments. The experimental design is 
depicted in Fig. 1. Mice were allowed free access to water 
and diets with variable fat content: CD, N = 14, control 
diet with 10% of kilocalories from fat (D12450B, Research 
Diets, New Brunswick, NJ, USA); HFD45, N = 10, an HFD 
with 45% of kilocalories from fat (D12451, Research Diets, 
New Brunswick, NJ, USA); HFD60, N = 16, an HFD with 
60% of kilocalories from fat (D12492, Research Diets, New 
Brunswick, NJ, USA). The full composition and FA proﬁle 
of the diets is available at http://www.researchdiets.com/
opensource-diets/stock-diets/dio-series-diets. Brieﬂy, the 
SFA/MUFA/PUFA percent composition was 22.7:29.9:47.4 
in CD, 31.4:35.5:33.1 in HFD45, and 32.0:35.9:32.0 in 
HFD60. All mice received the control diet during accli-
matization and received the experimental diets for at least 
26 weeks. A diet-induced metabolic phenotype was clearly 
installed at week 18, and we investigated its reversibility in 
a subset of mice in the HFD60 group (the group with the 
severest phenotype) by subjecting them to a dietary reversal 
to CD for the last 7 weeks (HFD60?CD, N = 5). Noninva-
sive 1H-MRS of the liver (see later) and oral glucose toler-
ance tests (OGTTs; 1.5 g/kg after a 6-h fast) were performed 
before exposure to the experimental diets (baseline) and after 
1, 4, 9, 18, and 26 weeks (Fig. 1). Additional measurements 
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Fig. 1  Experimental design. Mice were randomly assigned to 
four dietary regimens: CD (10% of kilocalories from fat, N  =  15), 
HFD45 (45% of kilocalories from fat, N  =  10), HFD60 (60% of 
kilocalories from fat, N = 16 until week 19 and N = 11 thereafter), 
and HFD60?CD (19 weeks of HFD60 followed by 7 weeks of CD, 
N = 5). At the baseline (bs) all groups had access to the control diet 
(CD). White arrows indicate the time points for experimental assess-
ments in all groups, and gray arrows indicate time points for experi-
mental assessments in the HFD60?CD group exclusively. Proton 
magnetic resonance spectroscopy (1H-MRS) was performed in vivo, 
longitudinally, for hepatic lipid characterization; and oral glucose 
tolerance tests (OGTTs) were done after a minimum 3-day resting 
period subsequent to the magnetic resonance session. If not otherwise 
stated, 1H-MRS measurements were performed with the mice in the 
fed state
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were performed at week 21 in the HFD60?CD group. Mice 
were allowed at least 3 days of rest between manipulations, 
and the time points in Fig. 1 represent the average testing 
times. Longitudinal 1H-MRS was performed in mice fed 
ad libitum, and an additional measurement was performed 
after an overnight fast at around week 18 in CD, HFD45, 
and HFD60 mice, and after dietary reversal, at around week 
26, in the HFD60?CD group. At the end of the study, mice 
anesthetized with isoﬂurane were killed by cervical dislo-
cation, blood was collected from the descending aorta for 
biochemical measurements, the livers were removed and 
immediately freeze-clamped in liquid-nitrogen-cooled metal 
thongs, and epididymal white adipose tissue (EWAT) was 
collected and weighed. Livers and plasma were stored at 
− 80 °C until further processing.
Hepatic lipid content and FA composition by 1H-MRS 
in vivo
Mice were anesthetized with isoﬂurane (4% for induction 
and 1–2% thereafter, in 70:30 air/oxygen), and placed in an 
in-house-built holder. Body temperature was continuously 
assessed by a rectal probe and maintained at 36–37 °C by 
a circulating warm water system. Respiratory rate was kept 
at 60–90 bpm by regulation of isoﬂurane delivery, and was 
continuously monitored with a magnetic resonance (MR)-
compatible system (SA Instruments, Stony Brook, NY, 
USA), which also delivered the necessary triggering signals 
for respiratory gating during the MR acquisitions. Mice were 
scanned in the supine position in a 26-cm horizontal bore 
14.1-T magnet interfaced with a VNMRS DirectDrive con-
sole (Varian, Palo Alto, CA, USA). A 1H quadrature surface 
coil (two 13-mm-inner-diameter physically decoupled loops) 
placed over the abdomen was used as the transreceiver. 
Automatic shimming to reduce magnetic ﬁeld inhomogenei-
ties was performed with FAST(EST)MAP [25]. Multislice 
gradient echo images were acquired in the sagittal, axial, and 
coronal orientations (85° ﬂip angle, 25 mm × 25 mm ﬁeld of 
view, 128 × 128 data matrix, and minimum repetition and 
echo times) for identiﬁcation of the liver and deﬁnition of a 
(2 × 2 × 2)  mm3 volume of interest for 1H-MRS. For consist-
ency, this volume was selected from the right medial lobe, 
which was identiﬁed visually by the experienced observer. 
Hepatic lipid content (HLC) was determined from localized 
1H-MR spectra acquired with the stimulated echo acquisi-
tion mode (STEAM) technique (8-ms echo time, 20-ms 
mixing time, 6.5-s repetition time, 4096 complex points, 32 
scans) as the peak area of methylene protons at 1.3 ppm (Lip 
1.3) relative to that of water plus Lip 1.3, with corrections 
for diﬀerences in spin–spin relaxation times as previously 
described [26]. The FA composition of intrahepatic lipids 
was characterized as previously described [26] with use of 
indices for saturation, number of double bonds, unsaturated 
FA, SFA, PUFA, MUFA, and mean chain length (Table 1). 
These indices were obtained from diﬀerent lipid resonances 
in spectra acquired with STEAM (2.8-ms echo time, 20-ms 
mixing time, 5-s repetition time, 2048 complex points, and 
86–128 scans) in combination with water suppression and 
outer volume saturation [27]. Individual spectra were cor-
rected for B0 drift and phase, summed, and analyzed with 
LCModel version 6.3-1E (LCMODEL) with use of SPTYPE 
liver-11 with automatic metabolite simulation.
Biochemical measurements
Blood glucose during the OGTT was measured from the tail 
tip with a glucometer (Breeze, Bayer, Zurich, Switzerland). 
Plasma hormones and metabolites were quantiﬁed with 
commercially available kits for insulin ELISA (Mercodia, 
Uppsala, Sweden), nonesteriﬁed FA (NEFA; Wako Chemi-
cal, Neuss, Germany), triglycerides (Analox, Stokesley, 
UK), leptin ELISA (Abcam, Cambridge, UK), adiponectin 
ELISA (Adipogen, Epalinges, Switzerland), and C-peptide 
ELISA (Crystal Chem, Downers Grove, USA). Blood ala-
nine transaminase (ALT) and aspartate transaminase (AST) 
levels were determined with a Reﬂotron blood analyzer 
(Roche Diagnostics, Rotkreuz, Switzerland).
Statistics
Numeric data are the mean ± standard error of the mean. For 
a given variable, diﬀerences between groups were assessed 
with a one-way ANOVA followed by Newman–Keuls 
Table 1  Fatty acid composition indices derived from proton mag-
netic resonance spectra of hepatic lipids
Chemically distinct fatty acyl protons are identiﬁed by their chemi-
cal shift in the proton magnetic resonance spectrum (see also Fig. 5a). 
For example, Lip 1.3 refers to the methylene protons at 1.3 ppm.
MUFA monounsaturated fatty acids, PUFA polyunsaturated fatty 
acids, SFA saturated fatty acids, UFA unsaturated fatty acids
a A correction factor of 1.15 [1/(1  −  0.13)] was used to account for 
an  approximately 13% underestimation of the number of double 
bonds with our acquisition parameters [1].
Fatty acid composition index Expression
Saturation index Lip 1.3× 3
Lip 0.9× 2
Number of double  bondsa Lip 5.3× 3
Lip 0.9× 2
× 1.15
UFA Lip 2.1× 3
Lip 0.9× 4
SFA 1 − UFA
PUFA or polyunsaturated bonds 
per fatty acid
Lip 2.8× 3
Lip 0.9× 2
MUFA UFA − PUFA
Mean chain length 1∕2(Lip 1.3+Lip 2.1+Lip 2.8) +Lip 5.3
1∕3×Lip 0.9
+ 4
344 Magn Reson Mater Phy (2018) 31:341–354
1 3
multiple comparison post hoc tests. A two-way ANOVA 
(with repeated measures) followed by Student’s t test cor-
rected for multiple comparisons was used to assess diﬀer-
ences when variables were measured over time. For com-
parisons of hepatic lipid parameters between the fasted and 
fed states, for each group a Student t test was performed with 
corrections for multiple comparisons. Statistical signiﬁcance 
was indicated by P < 0.05. Correlations were assessed with 
the Pearson r coeﬃcient.
Results
A phenotype of obesity, associated with perturbed metabolic 
variables, was clearly observed in mice fed HFD formulas. 
Body weight was signiﬁcantly higher in mice exposed to 
an HFD than in those exposed to CD, without diﬀerences 
in the average caloric intake per mouse during the 26-week 
experimental period (Fig. 2). On the other hand, within 1 
week of the reversal from HFD60 to CD (HFD60?CD 
group), caloric intake decreased to 3.8  ±  0.2  kcal/day 
(P < 0.001, Fig. 2), along with a signiﬁcant reduction of 
body weight from 48.5 ± 1.0 g to 43.5 ± 2.3 g (P < 0.05, 
Fig. 2). Afterwards, caloric intake in the HFD60?CD group 
progressively increased to levels similar to those observed 
in the other dietary groups, while body weight continued 
to decrease and reached values similar to those in the CD 
group at the end of the study (Fig. 2). Glucose tolerance 
was also signiﬁcantly perturbed by HFD feeding (Fig. 3a). 
Blood glucose level 2 h after the OGTT was higher in the 
HFD60 group than in the CD group by week 1 (P < 0.05) 
and remained well above the CD group values until the end 
of the study (Fig. 3b.). In parallel, the area under the curve 
for the entire period of the OGTT was also systematically 
higher in the HFD60 group than in the CD group (Fig. 3c). 
In the HFD45 group, blood glucose level 2 h after the OGTT 
was increased relative to that in the CD group at week 4 
(P < 0.01), week 9 (P < 0.01), and week 26 (P < 0.01) but 
not signiﬁcantly at week 18 (P = 0.1 after correction for 
multiple comparisons, Fig. 3b). Increases in the area under 
the curve reached statistical signiﬁcance only by week 26 
in the HFD45 group when compared with the CD group 
(Fig. 3c). After a 6-h fast, blood glucose levels in the HFD60 
group were higher than those in the CD group from week 
9 (P < 0.01) onward, while in the HFD45 group the lev-
els were higher than in the CD group at weeks 18 and 26 
(P < 0.01, Fig. 3d). Comparatively, fasting plasma insulin 
level progressively increased relative to that in the CD group 
in the HFD45 and HFD60 groups from week 4 (Fig. 3e). 
Taken together, these data show that perturbations of glu-
cose homeostasis, indicated by glucose intolerance and/or 
altered fasting blood glucose and plasma insulin levels, were 
detected within a few weeks of HFD feeding and were sus-
tained thereafter. In addition, derangements in the HFD60 
group had an earlier onset than those in the HFD45 group, 
and with time developed to be more pronounced. Similar to 
our observations for body weight, dietary reversal resulted 
in the recovery of glucose homeostasis. Fasting blood glu-
cose levels were normalized within 2 weeks (P < 0.0001 vs 
HFD60 group at week 18, Fig. 3d), while the recovery of 
fasting plasma insulin levels occurred gradually (P < 0.05, 
HFD60?CD group at week 21 vs HFD60 group at week 
18; and P < 0.01, HFD60?CD group at week 26 vs HFD60 
group at week 18; Fig. 3e). Fasting plasma insulin level 
in the HFD60?CD group was similar to that in the CD 
group by week 26 (Fig. 3e). Performance during the OGTT 
was completely normalized by the end of the study in the 
HFD60?CD group (Fig. 3a–c). 
At the end of the study, additional metabolic data were 
collected from postmortem measurements. Mice in the 
HFD45 and HFD60 groups displayed higher amounts of 
EWAT than mice in the CD group, and accordingly higher 
levels of circulating leptin but no diﬀerences in the levels 
of adiponectin (Table 2). The levels of NEFA in the plasma 
were also increased in the HFD45 and HFD60 groups rela-
tive to the CD group (Table 2), indicating inappropriate con-
trol of adipose tissue lipolysis. On the other hand, plasma 
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Fig. 2  Caloric intake (a) and body weight (b) during 26  weeks of 
exposure to experimental diets. CD control diet with 10% of kilocalo-
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HFD60 high-fat diet with 60% of kilocalories from fat, HFD60?CD 
HFD60 for 19 weeks followed by CD for 7 weeks
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triglyceride levels were similar among all groups (Table 2). 
Fasting plasma C-peptide levels were higher in the HFD45 
and HFD60 groups than in the CD group (Table 2), sug-
gesting increased insulin secretion in HFD-fed mice, in 
agreement with high fasting plasma insulin levels (Fig. 3d). 
Increased ALT and AST levels in the blood suggest the 
presence of liver damage in the HFD45 and HFD60 groups 
(Table 2). Metabolic variables in the HFD60?CD group 
were comparable to those in the CD group. However, the 
values of biomarkers for liver damage (ALT and AST) were 
in the range observed in the blood of mice in the HFD45 and 
HFD60 groups (Table 2).
With our longitudinal 1H-MRS measurements in vivo, 
we could monitor changes in hepatic lipids that accompa-
nied the metabolic dysregulation and recuperation induced 
by the dietary manipulations. Typically, these MR sessions 
lasted 45–75 min, including animal setup, imaging acquisi-
tions, and liver spectroscopy for HLC and FA composition. 
At weeks 18 and 26, images acquired from the abdominal 
region of mice in the HFD60 and HFD45 groups were dis-
tinguishable from those of CD mice as the former clearly 
showed visceral adipose tissue neighboring the liver, which 
was absent in the latter (e.g., Fig. 4a, b). HLC at the base-
line was (1.4 ± 0.2)% in the CD group, (1.2 ± 0.1)% in the 
HFD45 group, and (1.5 ± 0.2)% in the HFD60 group, as 
expected for nonmetabolically compromised mice. Accu-
mulation of lipids in the liver can be appreciated in the 1H-
MR spectra acquired longitudinally in vivo (Fig. 4c), and 
was noticeable within 4 weeks in both the HFD45 group 
(P < 0.01) and the HFD60 group (P < 0.05) when compared 
with the CD group (Fig. 4d). By week 26, HLC reached 
(8.3 ± 2.7)% in the HFD45 group (P < 0.05 vs CD group) 
and (17.6 ± 2.3)% in the HFD60 group (P < 0.001 vs CD 
group). When analyzing grouped data from all the time 
points, we found significant correlations between HLC 
and body weight in the CD, HFD45, and HFD60 groups 
(Fig.  4e–g). In the HFD60 group, strong linearity was 
observed until week 9 (shown in Fig. 4g), but from week 9 
to week 18 a greater increase of HLC with body weight was 
observed when compared with the previous period. Then, 
from week 18 to 26, HLC in the HFD60 group increased 
despite no striking changes in body weight (see also Fig. 2b). 
In the HFD60?CD group, HLC progressively attained con-
trol levels within 7 weeks (Fig. 4g). At the end of the study, 
HLC was (2.7 ± 0.4)% in the HFD60?CD group, similar 
to that in the CD group [(2.0 ± 0.3)%, Fig. 4d].
Besides the quantiﬁcation of HLC, we further charac-
terized the FA composition of hepatic lipids by 1H-MRS 
measurements in vivo acquired with suppression of the 
water peak (normally visible at 4.7 ppm). In this way, sev-
eral lipid resonances were revealed (Fig. 5a), from which 
FA composition indices were derived (Fig. 5b–g). By 
visual inspection, the hepatic spectral signatures of mice 
in the HFD45 and HFD60 groups can be distinguished 
from those of mice in the CD group. Notably, the lipid 
resonance at 2.8 ppm (Lip 2.8, denoting polyunsaturated 
bonds) was systematically higher in the HFD45 and 
HFD60 groups than in the CD group when spectra were 
scaled for the terminal methyl group at 0.9 ppm (depicted 
by the arrow in Fig. 5a). The terminal methyl group was 
used as an internal reference for normalization to one FA 
chain, as described in the expressions in Table 1. Thus, 
the calculated MR indices reﬂect the composition of FA 
chains in mobile cytosolic lipids, reporting a hypothetical 
FA with the average chain length and unsaturation char-
acteristics [26]. The average number of double bounds 
(Fig. 5b) was higher in the HFD60 group than in the CD 
group at almost all of the time point assessments, and was 
also higher in the HFD45 group than in the CD group at 
weeks 9 and 26. This ﬁnding was ascribed to an increase 
of polyunsaturation as denoted by the higher PUFA index 
(Fig. 5c), while the MUFA index (Fig. 5d) was comple-
mentarily reduced and no changes were noted in the SFA 
index (Fig. 5e) for both HFD regimens. In addition, the 
mean chain length was greater in the HFD60 group than 
in the CD group at weeks 4 and 26, and was greater in the 
HFD45 group than in the CD group at week 26 (Fig. 5f). 
No diﬀerences were observed between groups with regard 
to the saturation index (Fig.  5g). Dietary switch from 
HFD60 to CD caused an increase of the MUFA index to 
control values at week 21 (P < 0.05 vs HFD60 at week 18, 
Fig. 5d). These changes were accompanied by a tendency 
for a reduction in the SFA index at week 21 (P < 0.07 vs 
HFD60 at week 18) but no changes in the PUFA index. By 
week 26 all MR indices in the HFD60?CD group were 
similar to those in the CD group (Fig. 5b–g), indicating 
similar FA composition of hepatic cytosolic lipids.
Fasting-induced changes in hepatic lipids were inves-
tigated in the CD, HFD45, and HFD60 groups after 
18 weeks, when a clear metabolic phenotype was observed 
as described earlier. The response of hepatic lipids to fast-
ing in the HFD60?CD group was assessed after the die-
tary reversal period, at around week 26. We found higher 
plasma NEFA concentrations in fasted mice than in fed 
mice in the CD group (P < 0.0001) and the HFD60 group 
(P < 0.001) but not in the HFD45 group or the HFD60?CD 
group (Fig. 6a). Consistent with a fasting-induced release of 
NEFA from adipose stores in the CD group, HLC increased 
more than 1.5-fold with fasting: from (2.0  ±  0.2)% to 
(5.2 ± 0.4)% (P < 0.0001, Fig. 6b). The same trend was 
observed for the HFD45 group, with HLC increasing from 
(4.2 ± 0.7)% to (9.3 ± 1.2)% (P < 0.001, Fig. 6b), while in 
the HFD60 group, HLC was comparable between the fasted 
and fed states [(13.2 ± 2.5)% and (11.9 ± 2.1)%, respec-
tively, Fig. 6b]. Fasting-induced hepatic lipid accumula-
tion was restored in the HFD60?CD group, although the 
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relative increase was smaller than that in the CD group [from 
(2.7 ± 0.4)% to (4.5 ± 0.4)%, P < 0.05, Fig. 6b].
Fasting-induced changes in HLC were accompanied by 
alterations of the spectral signature of hepatic lipids assessed 
by 1H-MRS in vivo. There was a noticeable increase of 
the resonance at 2.8 ppm relative to that of the terminal 
methyl group at 0.9 ppm (Fig. 6c), and MR indices related 
to the unsaturation features of the FA chains were signiﬁ-
cantly altered between fed and fasted states in the CD group 
(Fig. 6d). In agreement with the spectral signatures, higher 
PUFA and lower MUFA indices were observed in fasted 
mice than in fed mice in the CD group. In the HFD45 group, 
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there was also an increase of the PUFA index with fasting, 
together with an increase in the average number of dou-
ble bounds, but without changes in the MUFA index. No 
changes of FA composition indices were observed in the 
HFD60 group with fasting, not even after 7 weeks of reversal 
to CD (HFD60?CD). Indices for chain length, SFA, and 
saturation were not signiﬁcantly altered by fasting in any 
group (not shown).
Discussion
This study reports for the ﬁrst time that changes in hepatic 
FA composition occur before hepatic steatosis in HFD-fed 
mice. Importantly, these qualitative changes resembled those 
caused by fasting, suggesting a similar hepatic response to 
increased inﬂux of FA. Ectopic lipid accumulation in the 
liver is a metabolically hazardous feature that accompanies 
obesity. To better understand the cause of this phenomenon 
in the scope of obesity-induced metabolic dysregulation, 
we characterized alterations in hepatic lipids and glucose 
homeostasis secondary to short-term and long-term expo-
sure to an HFD. Initial exposure to HFD formulas resulted 
in the immediate development of glucose intolerance, while 
prolonged exposure led to overt dysregulation of glucose 
homeostasis and hepatic steatosis. Overall, mice in the 
HFD60 group developed severer metabolic derangements 
and faster than those in the HFD45 group, as evaluated from 
OGTT parameters, fasting plasma insulin and blood glucose 
values, and HLC. These ﬁndings suggest that the amount 
of fat in the diet inﬂuences the degree of ensuing metabolic 
dysregulation.
We found that glucose tolerance was compromised 
within 1  week of HFD60 feeding, in good agreement 
with several studies evaluating short-term eﬀects of HFD 
feeding [3, 8, 28–30]. It was previously shown that glu-
cose intolerance induced by an approximately 9-week 
HFD-feeding protocol can be restored within 1 week by 
switching to a control diet [31]. Our study now demon-
strates that even after longer periods of exposure to an 
HFD, glucose tolerance is promptly reasserted in response 
to a reduction in dietary fat intake. However, this ﬁnding 
may be related to the striking decrease of caloric intake 
observed when the diet was switched from HFD60 to CD, 
in good agreement with observations from another study 
[4]. Restricted food intake per se is a strong regulator of 
glucose homeostasis in HFD models [30, 32] and likely 
plays an important role in the quick recovery of glucose 
tolerance in HFD60?CD mice.
During the OGTT, blood glucose level returns to basal 
values by the action of endogenous insulin. Glucose intol-
erance has been associated with beta-cell proliferation and 
hampered glucose-induced insulin secretion after 1 week 
of HFD feeding [3]. Therefore, an adaptation of pancreatic 
function could explain the diﬀerences in handling a glucose 
load in the acute HFD60 challenge, relative to CD. In addi-
tion to the beta-cell response, sensitivity to insulin action 
also guides the response to a glucose challenge. Direct 
assessments of hepatic insulin resistance with hyperinsuline-
mic–euglycemic clamps have provided evidence of impaired 
endogenous glucose production after a few days of HFD 
feeding [8, 9]. This defect also contributes to higher glu-
cose level excursions during the OGTT in HFD-fed rodents 
[33]. The former studies also report increased HLC after 
short-term HFD feeding. In this study, we found abnormally 
high fasting insulin levels, a surrogate of insulin resistance 
[34], at the same time when hepatic lipid accumulation was 
detected (i.e., from week 4) in both HFD groups. High fast-
ing insulin levels may indicate a compensatory secretion 
of insulin (compatible with our C-peptide measurements) 
in the context of insulin resistance. Distinct experimental 
conditions (animal’s age, dietary fat content, animal hous-
ing conditions) may account for the discrepancies regarding 
the onset of perturbed metabolic events between our study 
and other studies [8, 9, 29]. Insulin resistance was shown 
to correlate with liver fat in nonalcoholic fatty liver disease 
patients [35], and in metabolically healthy men, liver fat 
was found to be closely associated with fasting insulin lev-
els [36]. Similarly, we previously found a good correlation 
between liver fat in male mice and their metabolic status 
[37]. Hyperinsulinemia has been suggested to directly con-
tribute to increased FA uptake by the liver [38], an important 
mechanism by which lipids accumulate in the liver in HFD 
models [14, 15, 39]. The progressive decrease of HLC also 
paralleled the normalization of fasting insulin levels in the 
HFD60?CD group during the last 7 weeks of the study. 
Therefore, altogether, these studies conﬁrm a robust associa-
tion between HLC and insulin resistance/sensitivity.
Fig. 3  Glucose homeostasis during 26 weeks of exposure to experi-
mental diets. a Oral glucose tolerance tests (OGTTs; 1.5  g/kg after 
a 6-h fast) performed before (baseline, bs) and after 1, 4, 9, 18, and 
26  weeks of exposure to the test diets. In the group fed a high-fat 
diet with 60% of kilocalories from fat for at least 19 weeks followed 
by the control diet with 10% of kilocalories from fat for 7  weeks 
(HFD60?CD), an additional test was performed within 2  weeks 
of dietary reversal, and is represented in the 26-week plot. b Blood 
glucose level 2 h after the OGTT. c Area under the curve (AUC) for 
blood glucose level versus time during the full 2-h OGTT. d Fasting 
blood glucose and e fasting plasma insulin levels before the OGTT. 
The data are the mean with the standard error of the mean and were 
analyzed with a two-way ANOVA followed by Student’s t tests cor-
rected for multiple comparisons when diﬀerences from the group fed 
the control diet with 10% of kilocalories from fat (CD) were assessed 
across the diﬀerent time points. One asterisk P < 0.05, two asterisks 
P < 0.01, three asterisks P < 0.001, four asterisks P < 0.001 for high-
fat diet with 60% of kilocalories from fat (HFD60) versus CD; one 
section mark P  <  0.05, two section marks P  <  0.01, three section 
marks P < 0.001, four section marks P < 0.0001 for high-fat diet with 
45% of kilocalories from fat (HFD45) versus CD
◂
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Despite the absence of net hepatic lipid accumulation dur-
ing the ﬁrst few weeks of exposure to an HFD, we detected 
signiﬁcant diﬀerences in some indices of FA composition by 
1H-MRS in vivo: notably, higher PUFA and lower MUFA 
indices were observed in both HFD groups when compared 
with the CD group. These diﬀerences are unlikely to reﬂect 
the FA composition of the diets, which delivered similar 
proportions of PUFA sand MUFA in HFD formulas and a 
greater proportion of PUFA in CD. After overnight fast-
ing, HLC increased in the CD group, as expected [17–19]. 
This hepatic lipid deposition was accompanied by modiﬁ-
cations of the unsaturation indices similar to those induced 
by an HFD (i.e., increase of PUFA and reduction of MUFA 
indices).
Increased polyunsaturation of liver lipids with fasting has 
been reported previously [17, 19], and could reﬂect the pref-
erential release of PUFA from adipose tissue, as observed 
in starved rats [40]. However, since PUFA are minor con-
tributors to NEFA after an overnight fast [39], accumula-
tion of PUFA in the liver with fasting seems to be better 
explained by the privileged uptake and retention of PUFA 
relative to other FA [17]. This selective accumulation of 
PUFA in the liver, under conditions of lipid abundance, con-
tributes to curtail intrahepatic SFA levels, thereby limiting 
SFA-induced lipotoxicity [41]. This mechanism is clearly 
illustrated by the greater accumulation of lipids in the liver 
in rats fed a PUFA-rich diet versus rats fed an SFA-rich diet, 
and the presence of liver damage in the latter but not the 
former conditions [6]. Reduced MUFA index is consistent 
with an HFD-induced decrease of stearoyl-CoA desaturase 
1 (SCD-1) activity, converting SFA 16:0 and 18:0 to MUFA 
16:1 and 18:1 [39, 42, 43]. Moreover, the accumulation of 
PUFA in the liver both with fasting and HFD challenges 
will, in principle, have an inhibitory eﬀect on SCD-1 activity 
[44], thereby also contributing to a reduction of the levels 
of hepatic MUFA. The MUFA index immediately increased 
(along with a tendency for decreased SFA index) when die-
tary fat content was reduced from 60% of kilocalories to 
10% of kilocalories in the HFD60?CD group, in line with 
a modulation of SCD-1 activity by dietary fat load [43, 44]. 
Altogether, these data show that the FA composition of liver 
lipids changes dynamically in adaptation to lipid availability. 
Situations enhancing hepatic FA uptake (e.g., fasting or an 
HFD) lead to an immediate increase of PUFA levels in the 
liver, while a reduction of dietary fat load causes a reduc-
tion of the levels of those lipids. Importantly, alterations in 
hepatic FA composition induced by an HFD were detected 
before ectopic lipid accumulation in the liver and altered 
fasting blood insulin and/or glucose levels, which may be of 
relevance in the anticipation of diet-induced hepatic steatosis 
and associated metabolic dysregulation.
Early alterations of the hepatic lipid signature by HFD 
feeding were sustained throughout the study: the PUFA 
index in HFD-fed mice remained above control levels and 
the MUFA index remained below them, without striking 
changes in the SFA index. However, HLC increased signiﬁ-
cantly with prolonged exposure to an HFD, implying that 
the absolute levels of both PUFA and SFA increase. In good 
agreement with our observations, long-term HFD feeding 
has been shown to increase the amount of PUFA and SFA 
but not MUFA in hepatic triglycerides [45]. At the end of the 
study, we also found that the mean chain length was higher 
in hepatic FA in the HFD45 and HFD60 groups relative to 
the CD group, in line with increased hepatic FA elongation 
in long-term exposure to an HFD [45, 46].
Similarly to fasting-induced hepatic lipid accumulation 
[17, 19, 47], it is the surplus of adipose-tissue-derived-
NEFA in the liver that drives hepatic steatosis in HFD-fed 
rodents [14, 15, 39], as well as in patients with nonalco-
holic fatty liver disease [23]. Accordingly, we conﬁrmed 
Table 2  Metabolic variables 
after 26 weeks of exposure to 
experimental diets with diﬀerent 
fat contents
For each row, values not sharing a common superscript letter are signiﬁcantly diﬀerent (P < 0.05, one-way 
ANOVA with the Neuman–Keuls post hoc test). Values refer to mice fed ad libitum except for C-peptide 
level after a 6-h fast.
ALT alanine transaminase, AST aspartate transaminase, CD control diet with 10% of kilocalories from fat, 
EWAT epididymal white adipose tissue, HFD45 high-fat diet with 45% of kilocalories from fat, HFD60 
high-fat diet with 60% of kilocalories from fat, HFD60?CD HFD60 for 19  weeks followed by CD for 
7 weeks, NEFA nonesteriﬁed fatty acids
CD HFD45 HFD60 HFD60?CD
EWAT (g) 0.62 ± 0.06a 2.37 ± 0.10b 2.32 ± 0.14b 0.47 ± 0.04a
Leptin (pg/ml) 164.6 ± 13.5a 581.2 ± 67.3b 576.2 ± 69.7b 184.7 ± 13.6a
NEFA (mEq/l) 1.34 ± 0.18a 2.42 ± 0.15b 2.05 ± 0.14b 1.10 ± 0.26a
Triglycerides (mg/dl) 89.7 ± 12.5a 105.5 ± 6.3a 99.8 ± 14.8a 42.6 ± 7.2b
Glucose (mM) 9.0 ± 0.4a 9.1 ± 0.4a 10.8 ± 0.2b 8.4 ± 0.5a
C-peptide (ng/ml) 0.39 ± 0.24a 3.32 ± 1.47b 2.72 ± 0.83b 0.74 ± 0.52a
ALT (U/l) 21.5 ± 2.5a 132.6 ± 26.8b 110.5 ± 18.2b,c 53.6 ± 11.1a,c
AST (U/l) 76.4 ± 7.0a 202 4 ± 49.5b 164.6 ± 28.2a,b 139.1 ± 27.3a,b
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increased EWAT mass and plasma leptin and NEFA levels 
after 26 weeks in the HFD45 and HFD60 groups, together 
with hepatic steatosis. Conversely, in response to a relief of 
the dietary lipid load, the normalization of plasma NEFA 
and leptin levels in the HFD60?CD group was in good 
agreement with the reduction of EWAT mass. Reﬂecting 
the remodeling of lipid traﬃcking from adipose tissue to the 
liver, HLC was also normalized in the dietary switch group 
and triglyceride levels were reduced. In contrast to the lack 
of short-term changes in HLC on exposure to HFD formulas, 
a few weeks of dietary reversal from HFD60 to CD was suf-
ﬁcient to induce an eﬀective decrease of HLC. This rapid 
response was also observed in another study that performed 
a dietary switch from an obesogenic to a control diet [48].
Although not the main focus of this study, visceral fat 
depots were clearly visible in the MR images acquired at 
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Fig. 4  Diet-induced changes in hepatic lipid content (HLC) moni-
tored longitudinally by proton magnetic resonance spectroscopy 
in  vivo. Representative sagittal images of the abdominal region are 
shown for mice after 26 weeks in the group fed a high-fat diet with 
60% of kilocalories from fat (HFD60; a) and the group fed a control 
diet with 10% of kilocalories from fat (CD; b); visceral fat visible 
neighboring the liver of an HFD60 mouse is indicated by the arrow. 
c Representative proton magnetic resonance spectra acquired in vivo, 
longitudinally, from the liver of a mouse in the HFD60 group show-
ing the increase of the fatty acyl proton resonances (0–3 ppm) relative 
to the water signal at 4.7 ppm. The resonance areas of the methylene 
fatty acyl protons (Lip 1.3) and water, assigned in the spectra, were 
used to quantify the HLC. d Hepatic lipid accumulation [HFD60 and 
high-fat diet with 45% of kilocalories from fat (HFD45)] and regres-
sion on reversal from HFD60 to CD (HFD60?CD). HLC exhibited 
a linear relation with body weight in the CD group (e), HFD45 group 
(f), and HFD60 group (g), as depicted by the full lines. Linearity 
between HLC and body weight during reversal from HFD60 to CD 
(HFD60?CD) is depicted by the dotted line in g. Goodness of linear 
ﬁts is denoted by the R2 values in the graphs; P values assessing the 
diﬀerence from null slope are also shown. Numbers next to the sym-
bols in e–g indicate the number of weeks for which the mice had been 
fed the experimental diets. The data are the mean and standard error 
of the mean, and were analyzed with a two-way ANOVA followed by 
a Student t test corrected for multiple comparisons. bs baseline. One 
asterisk P < 0.05, two asterisks P < 0.01, three asterisks P < 0.001 
for HFD60 versus CD; one section mark P < 0.05, two section marks 
P < 0.01 for HFD45 versus CD
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weeks 18 and 26 in both HFD groups, but not in the CD 
group. This ﬁnding is in line with the notion that visceral 
fat mediates hepatic lipid accumulation in diet-induced 
obese mice, with implications for metabolic health [49]. 
A systematic study on fat depot distribution in mice with 
appropriate imaging techniques recently showed a strong 
correlation between visceral fat volume and EWAT mass 
[50]. In our study, EWAT mass was comparable between 
the HFD45 and HFD60 groups, but HLC in the HFD60 
group was about twice that in the HFD45 group. Pre-
sumably, a limited capacity for lipid storage in EWAT 
contributes to hepatic steatosis under HFD-feeding 
protocols.
Most metabolic biomarkers were normalized with the 
dietary intervention (e.g., glucose tolerance variables, fast-
ing plasma insulin, C-peptide, and blood glucose, HLC, 
leptin, EWAT). However, transaminase levels were still 
similar to those in HFD-fed mice, indicating the presence 
of liver damage. In addition, changes of hepatic lipids with 
fasting were not fully recovered in comparison with mice 
not exposed to an HFD. Namely, fasting induced an accu-
mulation of SFA and not necessarily PUFA, suggesting 
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Fig. 5  Hepatic fatty acid composition monitored by proton magnetic 
resonance (MR) spectroscopy in  vivo. a Representative proton MR 
spectra acquired with water suppression at week 4 from the livers 
of mice fed a control diet with 10% of kilocalories from fat (CD), a 
high-fat diet with 45% of kilocalories from fat (HFD45), and a high-
fat diet with 60% of kilocalories from fat (HFD60). Resonances from 
fatty acyl protons are identiﬁed in the CD spectrum and are labeled 
accordingly with their chemical shifts. Bold lettering indicates reso-
nances used to calculate MR indices of fatty acid (FA) composition 
(Table 1). Spectra are scaled to have the same intensity of Lip 0.9 so 
that the relatively higher intensity of Lip 2.8 (depicted by the arrow) 
in the HFD45 and HFD60 groups in comparison with the CD group 
can be appreciated. b–g Longitudinal evolution of the FA composi-
tion indices in the diﬀerent groups. Data are the mean and standard 
error of the mean, and were analyzed with a two-way ANOVA fol-
lowed by a Student t test corrected for multiple comparisons. One 
asterisk P < 0.05, two asterisks P < 0.01, three asterisks P < 0.001 
for HFD60 versus CD; one section mark P < 0.05, two section marks 
P  <  0.01, three section marks P  <  0.001 for HFD45 versus CD. 
HFD60?CD HFD60 for 9 weeks followed by CD for 7 weeks
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that mechanisms of FA uptake remain impaired. It is not 
clear whether a longer dietary reversal period would have 
allowed a complete normalization of hepatic lipid han-
dling. Several studies report that the resaturation of insulin 
sensitivity aﬀorded by lifestyle interventions in prediabe-
tes may be transient [35]. In nondiabetic obese patients 
following a low-caloric diet, the composition of circulat-
ing lipids was a predictor for improvements of long-term 
glycemic control [51]. Thus, whole-body lipid traﬃcking, 
as reﬂected in circulating and hepatic lipid proﬁles, is an 
important element accounting for long-term metabolic 
health.
Conclusion
In summary, the average polyunsaturation of hepatic FA 
increases promptly with HFD feeding, independently of the 
diet’s PUFA content, together with a decrease of glucose tol-
erance, and before net hepatic lipid accumulation is detected. 
HFD-induced changes in the hepatic FA composition resem-
bled those induced by fasting in mice that received a con-
trol diet. Therefore, we conclude from our observations that 
the hepatic FA composition is an early indicator of whole-
body lipid availability, responding to lipid traﬃcking from 
adipose tissue to the liver under HFD-feeding protocols. In 
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esteriﬁed fatty acids (NEFA). b Hepatic lipid content (HLC). c Rep-
resentative proton magnetic resonance (MR) spectra acquired in vivo 
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fasted overnight (Fasted) at around week 18 for the CD group, the 
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addition, because fasting-induced changes in HLC and FA 
composition were not completely normalized after a dietary 
intervention, we conclude that whole-body lipid traﬃcking 
remains perturbed long after the recovery of other metabolic 
markers.
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